Table 2.
The genotype frequencies for BMP-4 polymorphisms between responders and nonresponders.
| Responders | Nonresponders | Adjusted OR†, 95% CI | Adjusted P† | |||
|---|---|---|---|---|---|---|
| N = 364 | % | N = 562 | % | |||
| −5826G > A | ||||||
| GG | 112 | 31% | 184 | 32% | 1 | |
| GA | 171 | 47% | 283 | 49% | 0.99, 0.73–1.34 | 0.96 |
| AA | 81 | 22% | 107 | 19% | 1.24, 0.86–1.80 | 0.25 |
| G | 395 | 54% | 651 | 57% | 1 | |
| A | 333 | 46% | 497 | 43% | 1.12, 0.92–1.33 | 0.3 |
| 6007C > T | ||||||
| TT | 70 | 19% | 179 | 31% | 1 | |
| CT | 167 | 46% | 278 | 48% | 1.34, 0.98–2.11 | 0.051 |
| CC | 127 | 35% | 117 | 20% | 2.78, 1.91–4.03 | <0.001 |
| T | 307 | 42% | 636 | 55% | 1 | |
| C | 421 | 58% | 512 | 45% | 1.72, 1.41–2.05 | <0.001 |
†Adjusted with age, sex, smoke status, histology, stage, and chemotherapy agents.